Back

Remnant cholesterol-inflammatory index predicts antiplatelet reactivity and 5-year ischemic risk: a cohort study of 6,555 post-PCI patients

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (1) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Menglu Liu

Beijing (China)

6 More presentations in this session

Presentation thumbnail
Association of atherogenic index of plasma trajectory with the incidence of cardiovascular disease over a 12-year follow-up: findings from the ELSA cohort study
Doctor X. Li (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Small dense low-density lipoprotein cholesterol potentiates the risk of Lp(a) for long-term secondary prevention in patients with stable coronary artery disease
Professor S. Koba (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Coronary artery disease and the bad dual: homocysteine and lipoprotein (a)
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of cardiac myosin binding protein C in the general population: The Akershus Cardiac Examination 1950 Study
Doctor M. Lyngbakken (Nordbyhagen, NO)
Abstract Slides Video
Presentation thumbnail
Clonal Hematopoiesis and Cardiovascular Outcomes in the Elderly
Mr D. Ezzat (BE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact of glucose metabolism status on the relationship between remnant cholesterol and ischemic risk after percutaneous coronary intervention: a large-scale long-term cohort study from real-world
thumbnail
Congress Presentation
Sex-specific associations between remnant cholesterol and cardiovascular risk in patients undergoing percutaneous coronary intervention: a 5-year large-sample study from the real world
thumbnail
Congress Presentation
Long-term prognostic impact of remnant cholesterol distribution after percutaneous coronary intervention and coronary artery bypass graft: insights from a nationwide cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources